The global embolotherapy market is poised for significant growth, with projections indicating an increase from $4,018.0 million in 2024 to $6,447.1 million by 2030, reflecting a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2025–2030.
This expansion is primarily driven by the rising prevalence of chronic and lifestyle-associated diseases, advancements in medical technology, and increased healthcare expenditures. Additionally, the growing adoption of minimally invasive s
